Glutathione-S-transferase as a selective inhibitor of oncogenic ras-p21- induced mitogenic signaling through blockade of activation of jun by jun-N- terminal kinase

Annals of Clinical and Laboratory Science

Volumn 30, Issue 1, 2000, Pages 57-64

  Villafania, Artjohn ^a,b   Anwar, Kamran ^a,b   Amar, Shazia ^a,b   Chie, Lyndon ^a,b   Way, Denise ^a,b   Chung, Denise L ^b   Adler, Victor ^c   Ronai, Zeev ^c   Brandt Rauf, Paul W ^d   Yamaizumii, Ziro ^e   Kung, Hsiang Fu ^f   Pincus, Matthew R ^a,g  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LONG ISLAND UNIVERSITY   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d The New York Presbyterian Hospital   (United States)

^e CANCER INSTITUTE   (Japan)

^f NATIONAL CANCER INSTITUTE   (United States)

^g SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Glutathione S transferase; jun; jun kinase; Oocyte maturation; Protein kinase C; ras p21

Indexed keywords

GLUTATHIONE TRANSFERASE; JANUS KINASE; PROTEIN INHIBITOR; PROTEIN KINASE C; PROTEIN P21; RAS PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME BINDING; ENZYME INHIBITION; GENE ACTIVATION; GENE CONTROL; GENE FUNCTION; GENE INDUCTION; MITOGENESIS; NONHUMAN; OOCYTE MATURATION; PRIORITY JOURNAL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GLUTATHIONE TRANSFERASE; HYPOGLYCEMIC AGENTS; INSULIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGENS; OOCYTES; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION; XENOPUS LAEVIS;

EID: 0033965714     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mannervik B, Danielson UH. Glutathione transferases -structure and catalytic activity. CRC Crit Rev Biochem 1988; 23:283-337.
2. Kantor RRS, Giardina SL, Bartolazzi A., Townsend AJ, Myers CE, Cowan KH, Longo DL, Natali PG. Monoclonal antibodies to glutathione-S-transferase π. Immunohistochemical analyses of human tissues and cancers. Int J Cancer 1991; 47:193-201.
3. Kantor R, Eschenfelder P, Pincus MR. The pi-isozyme of glutathione S-transferase may be a serum marker for solid tissue (epithelial cell) tumors. Amer Assoc Clin Chem 1991; 43rd Annual Meeting, Washington, DC, Abstract #680.
4. Derijard B, Hibi M, Wu I, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNK1: A protein kinase-stimulated by UV light and Ha-ras that binds and phosphorylates the c-jun activation domain. Cell 1994; 76:1025-1037.
5. Adler V, Pincus MR, Brandt-Rauf PW, Ronai ZR Complexes of ras-p21 with jun-N-Kinase and c-jun Proteins. Proc Natl Acad Sci USA 1995; 92:10585-10589.
6. ras. J Biol Chem 1996; 271:23304-23309.
7. Amar S, Glozman A, Chung DL, Alder V, Ronai Z, Friedman FK, Robinson R, Brandt-Rauf PW, Yamaizumi Z, and Pincus MR. Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for design of selective chemotherapeutic agents. Cancer Chemo Pharmacol 1997; 41:79-85.
8. Barbacid M. ras genes. Ann Rev Biochem 1987; 56:779-827.
9. th Ed (Henry JB, Ed), WB Saunders Company, Philadelphia, 1996; pp 310-321.
10. Almoguerra C, Shibata D, Forrester K, Martin J, Arnheim M, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53:549-554.
11. Birchmeier C, Broek D, Wigler M. ras proteins can induce meiosis in Xenopus oocytes. Cell 1985; 43:615-621.
12. Pincus MR, Chung DL, Dykes DC, Brandt-Rauf PW, Weinstein IB, Yamaizumi Z, Nishimura S. Pathways for activation of the ras-oncogene-encoded p21 protein. Ann Clin Lab Sci 1992; 22:323-342.
13. Deshpande AK, Kung H-F. Insulin induction of Xenopus laevis oocyte maturation is inhibited by monoclonal antibody against p21 ras proteins. Mol Cell Biol 1988; 7:1285-1288.
14. Adler V, Vin Z, Fuchs SY, Benezra M, Freer S, Tew KD, Pincus MR, Kung H-F, Henderson CJ, Wolf CR, Davis R, Ronai Z. Regulation of JNK signaling by a monomer form of GSTp. EMBO J 1999; 18:1321-1334.
15. Chung DL, Brandt-Rauf PW, Weinstein IB, Nishimura S, Yamaizumi Z, Murphy RB, Pincus MR. Evidence that the ras-oncogene-encoded 21 protein induces oocyte maturation via activation of protein kinase C. Proc Natl Acad Sci USA 1992; 89:1993-1996.
16. Chung D, Villafania A, Anwar K, Amar S, Rijwani K, Kung H-F, Adler V, Ronai Z, Brandt-Rauf PW, Yamaizumi Z, Pincus MR. Mutual dependence of jun-N-terminal kinase and protein kinase C on the oncogenic ras-p21 protein-induced mitogenic signaling pathway. Med Sci Res 1998; 26:147-150.
17. Inouye Y, Nakamori H, Iwai S, Ohtsuka E, Ikehara M, Miura K, Noguchi S, Nishimura S. Synthesis and expression of a synthetic gene for the activated human c-Ha-ras protein. Jpn J Cancer Res (Gann) 1986; 77:45-51.
18. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249:7130-7139.
19. Simons PC, Vander Jagt DL. Purification of glutathione-S-transferases from human liver by glutathione affinity chromatography. Anal Biochem 1977; 82:334-341.
20. Chung DL, Joran A, Friedman FK, Robinson R, Brandt-Rauf PW, Weinstein IB, Ronai ZA, Baskin L, Dykes DC, Murphy RB, Nishimura S, Yamaizumi Z, Pincus MR. Evidence that oocyte maturation induced by an oncogenic ras p21 protein and insulin is mediated by overlapping yet distinct mechanisms. Exp Cell Res 1992; 203:329-335.
21. Meyer T, Regenass U, Fabbro D, Alteri E, Rosel J, Muller M, Caravatti G, Matter A. A derivative of staurosporine (CPG 41 251) shows selectivity for protein kinase C inhibition and in vivo anti-tumor activity. Int J Cancer 1989; 43:851-856.
22. Furth ME, Davis LJ, Fleurdelys B, Scolnick EM. Monoclonal antibodies to the p21 products of the transforming gene of harvey murine sarcoma virus and of the cellular ras-gene family. J Virol 1982; 43:294-304.
23. Holt KH, Kasson BG, Pessin GE. Insulin stimulation of MEK-dependent but ERK-independent SOS protein kinase. Mol Cell Biol 1996; 16:577-583.